Thus, these results demonstrate that upon DC-specific stimulation higher levels of secreted IL-12p70, TNF-α and MIP-1β and lower levels of TGF-β1 were found in melanoma patients responding to anti-PD1 treatment when compared to non-responders. Here, TGFB1 is linked to melanoma.